Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 28.70
+0.10 (0.35%)
Apr 14, 2026, 5:29 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 2.29 billion as of April 14, 2026. Its market cap has decreased by -33.46% in one year.
Market Cap
2.29B
Enterprise Value
1.75B
Revenue
2.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.70
Market Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 2.29B, a decrease of -44.34%. That is a compound annual growth rate of -27.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 2.28B | -21.48% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.13B |
| Vicore Pharma Holding AB | 2.81B |
| Egetis Therapeutics AB | 2.37B |
| Saniona AB | 2.10B |
| BioInvent International AB | 1.50B |
| Medivir AB | 1.39B |
| Genovis AB (publ.) | 1.31B |
| Xspray Pharma AB | 1.26B |